We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HOUSE PASSES STOCK OPTION BILL; BIOTECH FIRMS MAY BENEFIT
HOUSE PASSES STOCK OPTION BILL; BIOTECH FIRMS MAY BENEFIT
July 21, 2004
The House has passed legislation that would require companies to expense the stock options of only the five highest-paid company executives — a move praised by the biotechnology industry, which had opposed another government proposal requiring companies to expense all employee stock options.